Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Occasional Paper / Office of Health Economics

Citation Profile [Updated: 2024-11-03 20:16:59]
5 Years H Index
3
Impact Factor (IF)
0
5 Years IF
0
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2010 0 0.52 0 0 2 2 0 0 0 0 0 0 0.3
2011 0 0.62 0 0 2 4 2 0 2 2 0 0 0.37
2012 0.25 0.68 0.4 0.25 1 5 2 2 2 4 1 4 1 0 1 1 0.36
2013 0.33 0.66 0.17 0.2 1 6 11 1 3 3 1 5 1 0 0 0.35
2014 0 0.67 0 0 2 8 0 3 2 6 0 0 0.34
2015 0 0.65 0 0 1 9 0 3 3 8 0 0 0.36
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12013Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Sussex, J ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106.

Full description at Econpapers || Download paper

12
21982Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry. (1982). Hartley, Keith ; Maynard, A. In: Occasional Papers. RePEc:ohe:occpap:000332.

Full description at Econpapers || Download paper

3
32012The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?. (2012). Towse, Adrian ; Puig-Peiro, R ; Garrison, L. In: Occasional Papers. RePEc:ohe:occpap:000167.

Full description at Econpapers || Download paper

3
41981Price Comparisons of Identical Products in Japan, the United States and Europe. (1981). Reekie, W D. In: Occasional Papers. RePEc:ohe:occpap:000322.

Full description at Econpapers || Download paper

2
52011Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?. (2011). Towse, Adrian ; Garau, Martina ; Danzon, Patricia. In: Occasional Papers. RePEc:ohe:occpap:000191.

Full description at Econpapers || Download paper

2
62010New Drugs to Tackle Antimicrobial Resistance: EU Policy Options. (2010). Towse, Adrian ; Sharma, P. In: Occasional Papers. RePEc:ohe:occpap:000216.

Full description at Econpapers || Download paper

1
72011Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies. (2011). Mordoh, A. In: Occasional Papers. RePEc:ohe:occpap:000171.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12013Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Sussex, J ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106.

Full description at Econpapers || Download paper

3
Citing documents used to compute impact factor:
YearTitle
Recent citations